Gene: SERPINA1
Official Full Name: serpin family A member 1provided by HGNC
Gene Summary: The protein encoded by this gene is a serine protease inhibitor belonging to the serpin superfamily whose targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen activator. This protein is produced in the liver, the bone marrow, by lymphocytic and monocytic cells in lymphoid tissue, and by the Paneth cells of the gut. Defects in this gene are associated with chronic obstructive pulmonary disease, emphysema, and chronic liver disease. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2020]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02725 | SERPINA1 Knockout cell line (HCT 116) | Human | SERPINA1 | 1:2~1:4 | Negative | Online Inquiry |
KO02726 | SERPINA1 Knockout cell line (A549) | Human | SERPINA1 | 1:3~1:4 | Negative | Online Inquiry |
SERPINA1 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to lack the SERPINA1 gene, which encodes the alpha-1 antitrypsin protein. This protein plays a crucial role in protecting tissues from damage caused by proteolytic enzymes, especially in the lungs and liver. By utilizing these knockout cell lines, researchers can study the effects of SERPINA1 deficiency in great detail, providing key insights into various pathophysiological conditions such as alpha-1 antitrypsin deficiency, liver diseases, and emphysema.
The primary function of SERPINA1 Gene Knockout Cell Lines is to serve as a reliable model for investigating the molecular mechanisms underlying the consequences of SERPINA1 deficiency. Without the SERPINA1 gene, these cells exhibit heightened susceptibility to proteolytic damage, allowing for in-depth studies on cellular responses to stress and inflammation and the development of therapeutic strategies to combat enzyme-induced tissue damage. The knockout cell lines facilitate research into potential gene therapies, drug screening, and drug development, thus advancing clinical solutions for related diseases.
Scientifically, these knockout cell lines hold significant importance as they provide a controlled environment to investigate gene function and regulation, essential for research in molecular biology and biochemistry. They offer valuable applications in both basic and applied research settings, significantly contributing to the understanding of protease inhibition and the biology of associated diseases.
One of the notable advantages of our SERPINA1 Gene Knockout Cell Lines lies in their specificity and reproducibility, paired with rigorous validation protocols that ensure their reliability. Compared to traditional models, these cell lines provide a more accurate representation of the physiological processes involved, minimizing animal usage and enhancing ethical research practices.
For researchers and clinicians looking to delve into the complexities of SERPINA1-related conditions, these knockout cell lines represent a powerful tool essential for both experimental and translational studies. Companies and laboratories can benefit from our extensive expertise in genetic engineering and cell line development, ensuring high-quality products tailored to meet the demands of cutting-edge scientific research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.